Alembic Limited (ALEMBICLTD.NS) Stock Price, News & Chart

	ALEMBICLTD.NS	APLLTD.BO	IOLCP.BO	000739.SZ	INDOCO.BO	THEMISMED.BO
Market cap	25.12B	176.07B	55.54B	25.56B	19.77B	9.36B
P/E (TTM)	7.8	20.9	27.3	31.5	—	23.5
Forward P/E	2.0	18.3	17.5	21.4	34.9	—
Price/book	1.0	3.0	2.9	3.9	1.7	2.4
Dividend yield	2.53%	1.32%	0.54%	1.75%	0.09%	0.50%
1-year change	−5.09%	−0.91%	+102.42%	+43.01%	−19.23%	−15.42%
Today	+3.28%	−1.26%	+3.08%	+2.22%	+0.14%	+1.22%

Market cap

25.12B

176.07B

55.54B

25.56B

19.77B

9.36B

P/E (TTM)

7.8

20.9

27.3

31.5

—

23.5

Forward P/E

2.0

18.3

17.5

21.4

34.9

—

Price/book

1.0

3.0

2.9

3.9

1.7

2.4

Dividend yield

2.53%

1.32%

0.54%

1.75%

0.09%

0.50%

1-year change

−5.09%

−0.91%

+102.42%

+43.01%

−19.23%

−15.42%

Today

+3.28%

−1.26%

+3.08%

+2.22%

+0.14%

+1.22%

Company	Mkt cap	Price	Today
Alembic Pharmaceuticals LimitedAPLLTD.BO · Drug Manufacturers - Specialty & Generic	176.07B	895.75	−1.26%
IOL Chemicals and Pharmaceuticals LimitedIOLCP.BO · Drug Manufacturers - Specialty & Generic	55.54B	189.20	+3.08%
Apeloa Pharmaceutical Co.,Ltd000739.SZ · Drug Manufacturers - Specialty & Generic	25.56B	22.06	+2.22%
Indoco Remedies LimitedINDOCO.BO · Drug Manufacturers - Specialty & Generic	19.77B	214.50	+0.14%
Themis Medicare LimitedTHEMISMED.BO · Drug Manufacturers - Specialty & Generic	9.36B	101.58	+1.22%
The United Laboratories International Holdings Limited3933.HK · Drug Manufacturers - Specialty & Generic	15.37B	7.800	+6.41%
Iambic Therapeutics, Inc.IAM · Biotechnology	635.17M	13.40	−0.67%
Alkem Laboratories LimitedALKEM.NS · Drug Manufacturers - Specialty & Generic	620.54B	5,190.00	−0.51%

Company	Mkt cap	Price	Today
Quzhou Xin'an Development Co., Ltd.600208.SS · Hangzhou, China	22.46B	2.6400	+0.76%
Cathay Real Estate Development Co., Ltd.2501.TW · Taipei, Taiwan	24.41B	21.05	+4.47%
Chong Hong Construction Co., Ltd.5534.TW · Taipei, Taiwan	21.13B	67.00	+0.30%
AP (Thailand) Public Company LimitedAP.BK · Bangkok, Thailand	25.17B	8.00	+2.56%
Hubtown LimitedHUBTOWN.BO · Mumbai, India	25.88B	182.15	+0.61%
China Resources Land LimitedCHZ.F · Wan Chai, Hong Kong	25.67B	3.6000	+4.05%
Sansiri Public Company LimitedSIRI.BK · Bangkok, Thailand	25.31B	1.4400	+1.41%
Arkade Developers LimitedARKADE.NS · Mumbai, India	20.63B	111.14	+2.72%

Company	Mkt cap	Price	Today
Wihlborgs Fastigheter AB (publ)0A0I.IL · Real Estate Services	23.63B	72.05	+2.42%
China World Trade Center Co., Ltd.600007.SS · Real Estate Services	22.05B	21.89	0.00%
Cellnex Telecom, S.A.0R9C.IL · Real Estate Services	22.78B	26.95	+0.45%
Quzhou Xin'an Development Co., Ltd.600208.SS · Real Estate - Development	22.46B	2.6400	+0.76%
Onewo Inc.2602.HK · Real Estate Services	21.65B	18.870	+3.11%
Fabege AB (publ)0XPX.IL · Real Estate Services	23.27B	66.80	+0.64%
Hufvudstaden AB (publ)0GW3.IL · Real Estate - Diversified	23.61B	111.90	−0.71%
Cathay Real Estate Development Co., Ltd.2501.TW · Real Estate - Development	24.41B	21.05	+4.47%

Company	Mkt cap	Price	Today
Bank of Baroda LimitedBANKBARODA.BO · Vadodara, India	1.29T	249.10	+1.61%
L&T Technology Services LimitedLTTS.NS · Vadodara, India	448.28B	4,225.60	+2.23%
Deepak Nitrite LimitedDEEPAKNTR.NS · Vadodara, India	210.59B	1,544.00	−2.18%
Alembic Pharmaceuticals LimitedAPLLTD.NS · Vadodara, India	175.63B	893.50	−1.46%
INOX India LimitedINOXINDIA.BO · Vadodara, India	181.56B	1,995.85	+3.36%
Shaily Engineering Plastics LimitedSHAILY.NS · Vadodara, India	136.73B	2,972.70	−0.41%
Voltamp Transformers LimitedVOLTAMP.NS · Vadodara, India	100.55B	9,939.00	−0.77%
Banco Products (India) LimitedBANCOINDIA.NS · Vadodara, India	88.51B	618.80	+1.59%

Company	Mkt cap	Price	Today
Rojana Industrial Park Public Company LimitedROJNA.BK · life sciences · real estate · energy	11.62B	5.75	+0.88%
Alexandria Real Estate Equities, Inc.ARE · life sciences · real estate	8.01B	46.00	+8.80%
Sinil Pharmaceutical Co., Ltd.012790.KQ · life sciences · real estate	72.48B	6,270.00	0.00%
Innovative Industrial Properties, Inc.IIPR · life sciences · real estate	1.55B	56.33	+2.42%
Shandong Sinocera Functional Material Co., Ltd.300285.SZ · life sciences · real estate · energy	40.91B	41.03	+1.69%
Daewoong Co., Ltd.003090.KS · life sciences · real estate	699.49B	16,640.00	+3.48%
Hybio Pharmaceutical Co., Ltd.300199.SZ · life sciences · real estate	21.97B	24.87	+9.51%
Kilroy Realty CorporationKRC · life sciences · real estate	4.44B	37.83	+5.00%

Company	Mkt cap	Price	Today
Balmer Lawrie & Co. Ltd.BALMLAWRIE.NS · Correlation 0.53	28.04B	163.97	+0.20%
Alembic Pharmaceuticals LimitedAPLLTD.NS · Correlation 0.39	175.63B	893.50	−1.46%
Aarti Drugs LimitedAARTIDRUGS.NS · Correlation 0.37	40.63B	445.15	−2.34%
Advanced Enzyme Technologies LimitedADVENZYMES.NS · Correlation 0.33	30.66B	284.30	+2.12%

Company	Mkt cap	Price	Today
ALEMBIC PHARMA LTDAPLLTD.NS	175.63B	893.50	−1.46%
BALMER LAWRIE & CO LTDBALMLAWRIE.NS	28.04B	163.97	+0.20%
AARTI DRUGS LTD.AARTIDRUGS.NS	40.63B	445.15	−2.34%
BLISS GVS PHARMA LTDBLISSGVS.NS	67.28B	632.45	+2.08%
ADVANCED ENZYME TECH LTDADVENZYMES.NS	30.66B	284.30	+2.12%

Multibagg AI·3h agoPositive

Alembic Q2 FY27 profit rises 81% as EBITDA margin reaches 22%

Alembic Pharmaceuticals Limited reported Q2 FY27 revenue of Rs 2,603 crore, up 36% year on year, while profit attributable to shareholders rose 81% to Rs 335 crore and earnings before interest, tax, depreciation and amortisation (EBITDA)…

SAHI·4h agoPositive

Alembic Pharmaceuticals Receives USFDA Final Approval For Olopatadine In $20 Million US Market

Market snapshot: Alembic Pharmaceuticals Limited has secured final approval from the US Food & Drug Administration for its Abbreviated New Drug Application for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%. The OTC drug targets…

NVO LLY

News18·4h agoPositive

Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

New Delhi, Nov 5 (PTI) Drug firm Alembic Pharmaceuticals Ltd has received final approval from the US health regulator for its Abbreviated New Drug Application (ANDA) for Olopatadine Hydrochloride Ophthalmic Solution USP. The approved…

NVO LLY

ETPharma.com·8h agoPositive

Alembic Pharma Q2 net profit climbs 81% to ₹335 crore on US branded pivot

pharma.economictimes.indiatimes.com New Delhi: Gujarat-based Alembic Pharma reported a 81 per cent year-on-year (YoY) jump in net profit to Rs 335 crore for the second quarter ended September this year.Revenue from operations

BBIO

BusinessLine·12h agoPositive

Stocks in focus, Nov 5: Alembic Pharma, Northern Arc, V2 Retail, Cupid, NALCO, Bright Outdoor, Som Distilleries, Manipal Health

Market roundup: diverse corporate moves include Alembic-DifGen collaboration, Northern Arc’s ₹400cr fund close, V2-Cupid retail pact, NALCO’s smelter expansion, Bright Outdoor listing, Som Carlsberg extension, and Manipal Health land lease…

LLY JNJ

BusinessLine·21h agoPositive

Q2 Results Today Highlights: BSE, Sundaram Finance, Dabur, Nykaa, Lenskart, Alembic Pharma, Aurobindo Pharma, HUDCO, Apollo Hospitals, NHPC Q2 profit rises, Biocon, Zydus Life profit declines

Follow our stock market live updates here | Stay tuned to businessline for more. FSN E-Commerce Ventures (Nykaa): 36% increase in standalone PAT to ₹16.71 cr Lenskart Solutions: Standalone PAT rises 69.3% to ₹167.85 crore in Q2FY27…

InvestyWise·18h agoPositive

Alembic Pharmaceuticals receives USFDA approval for ophthalmic solution

Alembic Pharmaceuticals gets USFDA approval for eye drop InvestyWise Alembic Pharmaceuticals receives USFDA approval for ophthalmic solution Alembic Pharmaceuticals Limited has announced the receipt of final approval from the US Food &…

NVO

SRN News·1d agoPositive

India's Alembic Pharma profit jumps on strong US sales

• The company reported a consolidated profit of 3.35 billion rupees ($35.37 million) for the quarter ended September 30, up from 1.85 billion rupees a year earlier • Revenue from operations rose more than 36% to 26.03 billion rupees •…

NVO

SAHI·1d agoPositive

Alembic Pharma Reports Q2 Net Profit of ₹3.3 Billion as US Formulations Rise 77%

Alembic Pharmaceuticals posted a consolidated net profit of ₹3.3 billion in Q2, up from ₹1.85 billion YoY. The financial acceleration was spearheaded by a 77% YoY surge in its US formulations revenue, which reached ₹1,003 crore. Market…

BBIO

Multibagg AI·5d agoPositive

Alembic Pharmaceuticals Limited wins USFDA approval for Venetoclax

Alembic Pharmaceuticals Limited announced final approval from the US Food and Drug Administration (USFDA) on 30 October 2026 for Venetoclax tablets in 10 mg, 50 mg and 100 mg strengths. The approved application is therapeutically…

AZN

Days on the list

30 d

1 yr

Best

Trending

—

Install

Alembic Limited

Key statistics

Against its peers

Latest news